Electrical cardioversion of atrial fibrillation

Cardiology Clinics

Volumn 22, Issue 1, 2004, Pages 101-111

  Joglar, Jose A ^a   Kowal, Robert C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; DILTIAZEM; GLUCOSE; IBUTILIDE; INSULIN; IRBESARTAN; POTASSIUM; PROPAFENONE; QUINIDINE; VERAPAMIL;

ANTICOAGULATION; CARDIOVERSION; CLINICAL PROTOCOL; CLINICAL TRIAL; DIRECT CURRENT; ELECTRODE; EMBOLISM; ENERGY; GLUCOSE INFUSION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; IATROGENIC DISEASE; INSULIN INFUSION; INTERMETHOD COMPARISON; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SAFETY; SKIN INJURY; THERMAL INJURY; TREATMENT FAILURE; TREATMENT OUTCOME; WAVEFORM;

EID: 1642545651     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(03)00119-X     Document Type: Review

References (56)

1. Feinberg W.M., Blackshear J.L., Laupacis A., Kronmal R., Hart R.G. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med. 155:1995;469-473.
2. The Atrial Fibrillation Follow-Up of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 347:2002;1825-1833.
3. Lown B., Amarasingham R., Newman J. New method for terminating cardiac arrhythmias: use of synchronized capacitor discharge. JAMA. 182:1962;548-555.
4. Jones J., Swartz J., Jones R.E., Fletcher R. Increasing fibrillation duration enhances relative asymmetrical biphasic versus monophasic defibrillator waveform efficacy. Circ Res. 67:1990;376-384.
5. Fain E., Sweeney M., Franz M. Improved internal defibrillation efficacy with a biphasic waveform. Am Heart J. 117:1989;358-364.
6. Wyse D.G., Kavanagh K.M., Gillis A.M., Mitchell L.B., Duff H.J., Sheldon R.S., et al. Comparison of biphasic and monophasic shocks for defibrillation using a nonthoracotomy system. Am Cardiol. 71:1993;197-202.
7. Takata T.S., Page R.L., Joglar J.A. Automated external defibrillators: technical considerations and clinical promise. Ann Intern Med. 135:2001;990-998.
8. Ricard P., Levy S., Trigano J., Paganelli F., Daoud E., Man K.C., et al. Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. Am J Cardiol. 79:1997;815-816.
9. Joglar J.A., Hamdan M.H., Ramaswamy K.R., Zagrodzky J.D., Sheehan C.J., Nelson L.L., et al. Initial energy for elective external cardioversion of persistent atrial fibrillation. Am J Cardiol. 86:2000;348-350.
10. Pinski S.L., Sgarbossa E.B., Ching E., Trohman R.G. A comparison of 50 J versus 100 J shocks for direct current cardioversion of atrial flutter. Am Heart J. 137:1999;439-442.
11. Mittal S., Ayati S., Stein K.M., Schwartzman D., Cavlovich D., Tchou P.J., et al. Transthoracic cardioversion of atrial fibrillation. Comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation. 101:2000;1282-1287.
12. Page R.L., Kerber R.E., Russell J.K., Trouton T., Waktare J., Gallik D., et al. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation. J Am Coll Cardiol. 39:2002;1956-1963.
13. Elhendy A., Gentile F., Khandheria B.K., Hammil S.C., Gersh B.J., Bailey K.R., et al. Predictors of unsuccessful electrical cardioversion in atrial fibrillation. Am J Cardiol. 89:2002;83-86.
14. Kerber R., Martins J., Kienzle M., Constantine L., Olshansky B., Hopson R., et al. Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment. Circulation. 77:1988;1038-1046.
15. Ewy G.A. Effectiveness of direct current defibrillation: role of paddle electrode size. II. Am Heart J. 93:1977;674-675.
16. Dahl C.F., Ewy G.A., Warner E.D., Thomas E.D. Myocardial necrosis from direct current countershock. Circulation. 50:1974;956-961.
17. Kerber R.E. Transthoracic cardioversion of atrial fibrillation and flutter: standard techniques and new advances. Am J Cardiol. 78:1996;22-26.
18. Botto G.L., Politi A., Bonini W., Broffoni T., Bonatti R. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart. 82:1999;726-730.
19. Kirchhof P., Eckardt L., Loh P., Weber K., Fisher R., Seidl K., et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomized trial. Lancet. 360:2002;1275-1279.
20. Kerber R.E., Jensen S.R., Grayzel J., Kennedy J., Hoyt R. Elective cardioversion: influence of paddle electrode location and size on success rate and energy requirements. N Engl J Med. 305:1981;658-662.
21. Walsh S.J., McCarty D., McClelland A.J., Owens C.J., Trouton T.J., Harbinson M.T., et al. A comparison of antero-apical and antero-posterior pad positions for cardioversion of atrial fibrillation using biphasic impedance compensated defibrillation waveforms. Pacing Clin Electrophysiol. 26:2003;1101.
22. Pagan-Carlo L.A., Spencer K.T., Robertson C.E., Dengler A., Birkett C., Kerber R. Transthoracic defibrillation: importance of avoiding electrode placement on the female breast. J Am Coll Cardiol. 27:1996;449-452.
23. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol. 38:2001;1231-1265.
24. Ewy G.A., Hellman D.A., McClung S., Taren D. Influence of ventilation phase on transthoracic impedance and defibrillation effectiveness. Crit Care Med. 8:1980;164-166.
25. Kerber R.E., Grayzel J., Hoyt R., Kennedy J. Transthoracic resistance in human defibrillation: influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure. Circulation. 63:1981;676-682.
26. Cohen T.J., Ibrahim B., Denier D., Haji A., Quan W. Active compression cardioversion for refractory atrial fibrillation. Am J Cardiol. 80:1997;354-355.
27. Dahl C.F., Ewy G.A., Ewy M.D. Transthoracic impedance to direct current discharge: effect of repeated countershocks. Med Intrum. 10:1976;151-154.
28. Kerber R.E., Vance S., Schomer S.J., Mariano D.J., Charbonnier F. Transthoracic defibrillation: effect of sternotomy on chest impedance. J Am Coll Cardiol. 20:1992;94-97.
29. Gale D.W., Grissom T.E., Mirenda J.V. Titration of intravenous anesthetics for cardioversion: a comparison of propofol, methohexital, and midazolam. Crit Care Med. 21:1993;1509-1513.
30. Rossi M., Lown B. The use of quinidine in cardioversion. Am J Cardiol. 19:1967;234-238.
31. Saliba W., Juratli N., Chung M.K., Niebauer M.J., Erdogan O., Trohman R., et al. Higher energy synchronized external direct current cardioversion for refractory atrial fibrillation. J Am Coll Cardiol. 34:1999;2031-2034.
32. Oral H., Souza J., Michaud G., Knight B., Goyal R., Strickberger S., et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med. 340:1999;1849-1854.
33. Capucci A., Villani G.Q., Aschieri D., Rosi A., Piepoli M.F. Oral amiodarone increases the efficacy of direct current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J. 21:2000;66-73.
34. VanNoord T., VanGelder I.C., Schoonderwoerd B.A., Crijins H.J.G.M. Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm on amiodarone. Am J Cardiol. 86:2000;1384-1385.
35. Bianconi L., Mennuni M., Lukic V., Castro A., Chieffi M., Sanatini M. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo controlled study. J Am Coll Cardiol. 28:1996;700-706.
36. DeSimone A., Stabile G., Vitale D.F., Turco P., DiStasio M., Petrazzuoli F., et al. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol. 34:1999;810-814.
37. Madrid A.H., Bueno M.G., Rebollo J.M.G., Marin I., Pena G., Bernal E., et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation. A prospective randomized study. Circulation. 106:2002;331-336.
38. Tse H.F., Lau C.P., Camm A.J. Transvenous atrial defibrillation - techniques and clinical applications. Clin Cardiol. 22:1999;614-622.
39. Boriani G., Biffi M., Camanini C., Luceri R.M., Branzi A. Transvenous low energy internal cardioversion for atrial fibrillation: a review of clinical applications and future developments. Pacing Clin Electrophysiol. 24:2001;99-107.
40. Boriani G., Biffi M., Camanini C., Bacchi L., Zannoli R., Luceri R.M., et al. Predictors of atrial defibrillation threshold in internal cardioversion. Pacing Clin Electrophysiol. 21:2000;1898-1901.
41. Gasparini G., Bonso A., Themistoclakis S., Giada F., Raviele A. Low-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up. Europace. 3:2001;90-95.
42. De Ridder S., Stroobandt R., Goethals M. Internal cardioversion: a worthwhile alternative after failed external cardioversion in obese patients. Acta Cardiol. 57:2002;225-228.
43. Verdino R.J., Teuteberg J.J., Burke M.C., Kopp D.E., Johnson C.T., Lin A.C., et al. Successful external cardioversion of atrial fibrillation in patients referred to an electrophysiologist for internal cardioversion. Clin Cardiol. 24:2001;500-502.
44. Zeiler Arnold A., Mick M.J., Mazurek R.P., Loop F.D., Trhoman R.G. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or flutter. J Am Coll Cardiol. 19:1992;851-855.
45. Klein A.L., Grimm R.A., Murray D., Apperson-Hansen C., Asinger R.W., Black I.W., et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 344:2001;1411-1420.
46. Bjerkelund C.J., Orning O.M. The efficacy of anticoagulation therapy in preventing embolism related to DC electrical conversion of atrial fibrillation. Am J Cardiol. 23:1969;208-216.
47. Lanzarotti C.J., Olshansky B. Thromboembolism in chronic atrial flutter: is the risk underestimated? J Am Coll Cardiol. 30:1997;1506-1511.
48. Sparks P.B., Kalman J.M. Is atrial flutter a risk factor for stroke? J Am Coll Cardiol. 38:2001;785-788.
49. Jakobson J., Odmasson I., Nordlander R. Enzyme release after elective cardioversion. Eur Heart J. 11:1990;749-752.
50. Georges J., Spentchian M., Caubel C., Collignon I., Schwob J., Livarek B., et al. Time course of troponin I, myoglobin, and cardiac enzyme release after electrical cardioversion. Am J Cardiol. 78:1996;825-827.
51. Neumayr G., Hagn C., Ganzer H., Friedrich G., Pechlaner C., Joannidis M., et al. Plasma levels of troponin T after electrical cardioversion of atrial fibrillation and flutter. Am J Cardiol. 80:1997;1367-1369.
52. Allan J., Feld R., Russell A., Landenson J., Rogers M., Kerber R., et al. Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion. J Am Coll Cardiol. 30:1997;1052-1056.
53. Van Gelder I.C., Crijns H.J., Van der Laarse A., Van Gilst W.H., Lie K.I. Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter. Am Heart J. 121:1991;51-56.
54. Zelinger A.B., Falk R.H., Hood W.B. Electrical-induced sustained myocardial depolarization as a possible cause for transient ST elevation post-DC elective cardioversion. Am Heart J. 103:1982;1073-1074.
55. Pagan-Carlo L.A., Stone M.S., Kerber R.E. Nature and determinants of skin burns after transthoracic cardioversion. Am J Cardiol. 79:1997;689-691.
56. Ewy G.A. The optimal technique for electrical cardioversion of atrial fibrillation. Clin Cardiol. 17:1994;79-84.